Management Team

Dr. Jerome B. Zeldis, M.D., Ph.D.

Chief Medical Officer – ViralClear Pharmaceuticals; Director – BioSig Technologies

Dr. Jerome B. Zeldis, M.D., Ph.D.

Dr. Jerome B. Zeldis, M.D., Ph.D.

Chief Medical Officer – ViralClear Pharmaceuticals; Director – BioSig Technologies

Dr. Zeldis has served as Executive Chairman of ViralClear Pharmaceuticals since March of 2020 and has served on the board of BioSig Technologies since June of 2019. He previously served as Chief Medical Officer and President of Clinical Research, Medical Affairs Drug Safety, Quality, and Regulatory at Sorrento Therapeutics, Inc. He attended Brown University for an AB, MS, followed by Yale University for an MPhil, MD, and Ph.D. in Molecular Biophysics and Biochemistry. Dr. Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and in Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He was Assistant Professor of Medicine at the Harvard Medical School, Associate Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, New Jersey. Dr. Zeldis is a named inventor on 43 US patents, has published 122 peer reviewed articles and 24 reviews, book chapters, and editorials.

Steve King

Chief Operating Officer

Steve King

Steve King

Chief Operating Officer

  • Seasoned pharmaceutical industry leader with 35+ years of relevant experience
  • Worked on 500+ small molecule programs over his career, many from inception through to commercial launch
  • Current President of 21159Pharma, which focuses on Licensing and CMC drug development
  • Former Senior Vice President and Head of Business Development at Pii
  • Former experience working at Janssen (J&J company) and R P Scherer (Catalent)